Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
about
Recurrence of autoimmune liver diseases after liver transplantationAutoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future ResearchPrimary biliary cirrhosis and liver transplantationPrimary biliary cirrhosis: Pathophysiology, clinical presentation and therapyThe immunoreactive patient: Rejection and autoimmune diseaseWhy Doesn't Primary Biliary Cholangitis Respond to Immunosuppressive Medications?Long-term outcome of living donor liver transplantation for primary biliary cirrhosis.Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic studyRole of novel retroviruses in chronic liver disease: assessing the link of human betaretrovirus with primary biliary cirrhosisThe Cholangiopathies.Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation.Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?Liver Transplantation for Cholestatic Liver Diseases in AdultsIs there a role for cyclophilin inhibitors in the management of primary biliary cirrhosis?The unfinished business of primary biliary cirrhosisSwitching from tacrolimus to cyclosporine A to prevent primary biliary cirrhosis recurrence after living-donor liver transplantation.Transplantation in autoimmune liver diseases.Recurrent nonviral liver disease following liver transplantation.Recurrence of non-viral liver disease after orthotopic liver transplantation.Gut-liver axis: an immune link between celiac disease and primary biliary cirrhosis.Liver transplantation and autoimmune liver diseases.Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis.Diagnosis and management of primary biliary cirrhosis.Differences in long-term survival among liver transplant recipients and the general population: a population-based Nordic study.Recurrence of autoimmune liver diseases after liver transplantation: clinical aspectsLate liver function test abnormalities post-adult liver transplantation: a review of the etiology, investigation, and management.Emerging drugs for the treatment of Primary Biliary Cholangitis.Obeticholic acid for the treatment of primary biliary cholangitis.Systematic review: recurrent autoimmune liver diseases after liver transplantation.Nonalcoholic fatty liver disease following liver transplantation.Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid.Is disease recurrence still relevant to graft survival?Disease recurrence plays a minor role as a cause for retransplantation after living-donor liver transplantation for primary biliary cirrhosis: A multicenter study in Japan.The impact of disease recurrence on graft survival following liver transplantation: a single centre experience.Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation.Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patients.Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study.Primary biliary cirrhosisGuidelines for the management of primary biliary cirrhosis
P2860
Q26774539-F4258220-5652-4179-96F6-AD2A134EF2A0Q26786188-544C5B84-9D3A-42A6-B2F7-A15DF4D4F336Q26853145-76A10C3C-3693-4779-BEFB-F227612B66E2Q26853649-90369A18-9036-49D5-BE52-8F1158E7586EQ26860876-F5709AA4-9C3E-4956-84F3-1EA5514E578BQ33840969-489BCB0B-9331-4F9B-BA25-7B0FBED13580Q34216929-40739FE1-D0E0-4BA6-9302-AE92F228A417Q34941664-C3DF5EB6-E765-41AD-95ED-CC912660F6EAQ35159893-A7193E98-082E-4FA6-B1D9-3608FD97A88DQ35942610-79A18836-9BDC-43CC-9DB6-0E904186827EQ36094924-D9A924CD-2478-469C-A3BC-2726B1E26423Q36197335-C8D17885-73B8-45A3-B9EE-1D8FCC68F81FQ36248162-8C60D906-BFA4-4C7F-A852-D04EA1297236Q36320523-880275C0-51E6-4148-B459-7E935054CF02Q36807116-A3B3C410-C26E-4A5B-B2EA-F7196D578CA2Q36914332-DE156F06-81A1-4233-B8ED-A4A00AA276E3Q37044781-C3F7B9E0-5911-457F-92AD-B146C29654B0Q37182962-8F56E6EB-394B-4761-82D6-76F9FB73F4FEQ37503375-62801025-782D-4764-98CF-54770898E16DQ37833670-8441B52B-5F42-4D45-A307-BFD715550203Q38085065-D3B69B26-D3BA-4C91-A536-B7440C25DE18Q38123133-DBE26B10-573D-4CB1-ABDD-E88CB449D368Q38174167-157D1C28-2A0C-4A07-AFDC-D45ECC68831DQ38266358-ACA6261A-E19E-46D5-8D8E-A2173B9A1F6CQ38418542-53FE5DCA-1914-48BD-874E-B63B202F72FDQ38497430-155A194F-36B3-4669-8EA1-5CFB4D41B051Q38646776-0A8A9C17-6F66-4853-94AB-F31B2A0EBE14Q38744215-1EA372D5-B754-4127-8872-A366DD4E247FQ38911238-3CC9D1F8-0D48-4777-A0A1-ECF466F6FF65Q39037242-5469F6C1-39AA-4822-ACF9-37D6B7913806Q40707333-36F69641-5A8D-4BEB-BB3C-538ED98C3B14Q40959951-B919F2E9-7D25-4550-8F54-FE30DC81BB8CQ43537358-76546E19-7D2D-466E-BC72-048006DA968EQ45373096-09D889D7-7ACC-4DB7-A89E-D25F21D09832Q46787456-2A62C136-C834-41CD-8610-54A387CEBC1AQ51331002-44F1CE4A-DB66-4CA8-AB9C-2B13CA6A20EDQ51636027-04651BD6-7C37-4004-B7E7-C47C7D9DC2D7Q55143923-537D21EF-C73A-4A27-B130-4F9B4C6F6CB7Q56428273-490C65FD-034F-4985-85E5-B5F89891A0DFQ56429943-31090915-18F8-45EE-B4C0-8A65E339A3D6
P2860
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Long-term survival and impact ...... s after liver transplantation.
@en
Long-term survival and impact ...... s after liver transplantation.
@nl
type
label
Long-term survival and impact ...... s after liver transplantation.
@en
Long-term survival and impact ...... s after liver transplantation.
@nl
prefLabel
Long-term survival and impact ...... s after liver transplantation.
@en
Long-term survival and impact ...... s after liver transplantation.
@nl
P2093
P356
P1476
Long-term survival and impact ...... s after liver transplantation.
@en
P2093
Jayant A Talwalkar
Keith D Lindor
Phunchai Charatcharoenwitthaya
Russell H Wiesner
Ruud A F Krom
Sylvania Pimentel
P304
P356
10.1002/LT.21124
P577
2007-09-01T00:00:00Z